Contrasting Cardiovascular Mortality Trends in Eastern Mediterranean Populations: Contributions from Risk Factor Changes and Treatments
Overview
Authors
Affiliations
Background: Middle income countries are facing an epidemic of non-communicable diseases, especially coronary heart disease (CHD). We used a validated CHD mortality model (IMPACT) to explain recent trends in Tunisia, Syria, the occupied Palestinian territory (oPt) and Turkey.
Methods: Data on populations, mortality, patient numbers, treatments and risk factor trends from national and local surveys in each country were collated over two time points (1995-97; 2006-09); integrated and analysed using the IMPACT model.
Results: Risk factor trends: Smoking prevalence was high in men, persisting in Syria but decreasing in Tunisia, oPt and Turkey. BMI rose by 1-2 kg/m(2) and diabetes prevalence increased by 40%-50%. Mean systolic blood pressure and cholesterol levels increased in Tunisia and Syria. Mortality trends: Age-standardised CHD mortality rates rose by 20% in Tunisia and 62% in Syria. Much of this increase (79% and 72% respectively) was attributed to adverse trends in major risk factors, occurring despite some improvements in treatment uptake. CHD mortality rates fell by 17% in oPt and by 25% in Turkey, with risk factor changes accounting for around 46% and 30% of this reduction respectively. Increased uptake of community treatments (drug treatments for chronic angina, heart failure, hypertension and secondary prevention after a cardiac event) accounted for most of the remainder.
Discussion: CHD death rates are rising in Tunisia and Syria, whilst oPt and Turkey demonstrate clear falls, reflecting improvements in major risk factors with contributions from medical treatments. However, smoking prevalence remains very high in men; obesity and diabetes levels are rising dramatically.
Ghammam R, Maatoug J, Harrabi I, Ben Fredj S, Zammit N, Laatikainen T J Hum Hypertens. 2022; 38(4):336-344.
PMID: 35396538 PMC: 11001574. DOI: 10.1038/s41371-022-00672-2.
Bending the Curve in Cardiovascular Disease Mortality: Bethesda + 40 and Beyond.
Goff Jr D, Khan S, Lloyd-Jones D, Arnett D, Carnethon M, Labarthe D Circulation. 2021; 143(8):837-851.
PMID: 33617315 PMC: 7905830. DOI: 10.1161/CIRCULATIONAHA.120.046501.
Adverse risk factor trends limit gains in coronary heart disease mortality in Barbados: 1990-2012.
Sobers N, Unwin N, Samuels T, Capewell S, OFlaherty M, Critchley J PLoS One. 2019; 14(4):e0215392.
PMID: 30995272 PMC: 6469800. DOI: 10.1371/journal.pone.0215392.
Abassi M, Sassi S, El Ati J, Ben Gharbia H, Delpeuch F, Traissac P Nutr J. 2019; 18(1):18.
PMID: 30898119 PMC: 6427851. DOI: 10.1186/s12937-019-0442-6.
Phillimore P, Sibai A, Rizk A, Maziak W, Unal B, Abu Rmeileh N Glob Health Action. 2019; 12(1):1569838.
PMID: 30721116 PMC: 6366406. DOI: 10.1080/16549716.2019.1569838.